Expansion funding Genial Care secured multiple fundraising rounds led by General Catalyst, including a $10M round in January 2024 and a subsequent $7.97M Series B in March 2026, signaling strong growth runway and potential for partner-enabled scaling in additional Latin American markets.

ASD care focus Specialization in autism spectrum disorder care for children, families, and therapists positions Genial Care as a strategic partner for payer, education, and clinic networks seeking integrated neurodevelopment services and evidence-based therapy models.

Tech-forward platform Use of a robust tech stack (Looker, Google Ads, analytics, CRM/automation, payments, and patient engagement tools) enables data-driven outreach, personalized programs, and scalable service delivery—opportunities for technology partnerships, integrations, and co-marketing with healthtech platforms.

Small revenue, high growth Current revenue under $1M with rapid fundraising activity suggests aggressive growth plans and potential for early adoption partnerships with clinics, schools, or therapy networks seeking to scale autism care services efficiently.

Market positioning Positioned as a Latin America reference for atypical health care with a focus on outcomes and wellbeing, offering a compelling value proposition for public tenders, private insurers, and international collaborations aiming to enhance ASD intervention capacity.